Progress in the clinical application of fractional exhaled nitric oxide in diagnosis and treatment of bronchial asthma
Fractional exhaled nitric oxide （FeNO） is a biomarker of type 2 inflammation， and produced by nitric oxide synthase （NOS） expressed on the airway epithelial cells， with the substrates of <i>L</i>-arginine and oxygen. Type 2 cytokines such as interleukin （IL）-4 and IL-13 can up-regulate i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of New Medicine
2024-10-01
|
| Series: | Xin yixue |
| Subjects: | |
| Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1731477158347-591820537.pdf |